Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn… - Clinical Microbiology …, 2022 - Elsevier
Background Vaccines are critical cost-effective tools to control the coronavirus disease 2019
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
M Sadarangani, A Marchant… - Nature Reviews …, 2021 - nature.com
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing
antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
[HTML][HTML] Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
The emergence of SARS-CoV-2 variants with evidence of antibody escape highlight the
importance of addressing whether the total CD4+ and CD8+ T cell recognition is also …
importance of addressing whether the total CD4+ and CD8+ T cell recognition is also …
Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines
MG Thompson, JL Burgess, AL Naleway… - … England Journal of …, 2021 - Mass Medical Soc
Background Information is limited regarding the effectiveness of the two-dose messenger
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study …
VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk… - The Lancet, 2021 - thelancet.com
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
[HTML][HTML] Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care …
MG Thompson - MMWR. Morbidity and Mortality Weekly Report, 2021 - cdc.gov
Prospective cohorts of 3,950 health care personnel, first responders, and other essential and
frontline workers completed weekly SARS-CoV-2 testing for 13 consecutive weeks. Under …
frontline workers completed weekly SARS-CoV-2 testing for 13 consecutive weeks. Under …
[PDF][PDF] COVID-19 weekly epidemiological update, edition 43, 8 June 2021
World Health Organization - 2021 - apps.who.int
Global case and death incidences continued to decrease with over 3 million new weekly
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
Effect of vaccination on transmission of SARS-CoV-2
Effect of Vaccination on Transmission of SARS-CoV-2 | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
INTRODUCTION As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic continues, the deployment of safe and effective vaccines presents a key …
pandemic continues, the deployment of safe and effective vaccines presents a key …
The effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data
Abstract Background Coronavirus disease 2019 (COVID-19) messenger RNA (mRNA)
vaccines were shown to be highly efficacious in preventing the disease in randomized …
vaccines were shown to be highly efficacious in preventing the disease in randomized …